Skip to content

ASSOCIATION BETWEEN OBESITY PHENOTYPES, METABOLIC HEALTH AND NAFLD

Association between different obesity phenotypes, liver steatosis and fibrosis and metabolic health in adult patients with Non-alcoholic fatty liver disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047422
Enrollment
400
Registered
2022-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

Intervention1: NIL: OBSERVATIONAL STUDY Intervention2: Metabolically Unhealthy Non Obese (MUNO) : Metabolically Unhealthy Non Obese (MUNO) Intervention3: Metabolically Unhealthy Obese (MUO): Metaboli

Sponsors

AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18-60 years Diagnosed with non- alcoholic fatty liver disease BMI above 18.5 kg/m2

Exclusion criteria

Exclusion criteria: Known case or recently diagnosed diabetes mellitus Acute infection and advanced end organ damage History of pancreatitis Participants undergone any recent surgery On any medication within last one month which could potentially influence insulin secretion, insulin sensitivity Pregnancy and lactation at the time of study. Chronic heart disease and chronic kidney disease Acute and chronic hepatitis Excessive alcohol use ( >20 g a day for women and >30 g for men)

Design outcomes

Primary

MeasureTime frame
Liver steatosis, liver fibrosis, biochemical and metabolic parameters (lipid profile, liver health markers and anthropometric parameters)Timepoint: One Time (At baseline only)

Secondary

MeasureTime frame
ASCVD risk score, FIB-4 Score, NFS Score, Muscle strength, quality of life and sleep qualityTimepoint: One Time (At Baseline only)

Countries

India

Contacts

Public ContactNaval K Vikram

All India Institute of Medical Science

navalvikram@gmail.com9810007331

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026